{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-083513","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2023-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.442270+00:00","generated_at":"2026-06-08T22:47:29.713283+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"60 Degrees Pharmaceuticals receives Nasdaq deficiency notice for bid price non-compliance","bullets":["On Nov 2, 2023, Nasdaq notified SXTP that its common stock failed to maintain minimum $1.00 closing bid price for 30 consecutive business days through Nov 1, 2023.","The company has a 180-day compliance period until April 30, 2024 to regain compliance with the Bid Price Rule.","If not compliant by April 30, 2024, SXTP may be eligible for an additional 180-day period if it meets other listing standards.","Failure to regain compliance may result in delisting of common stock and warrants from Nasdaq Capital Market.","The company is evaluating options to regain compliance, including potential reverse stock split."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-083513","json":"https://secwatch.observer/filing/0001213900-23-083513.json","markdown":"https://secwatch.observer/filing/0001213900-23-083513.md","text":"https://secwatch.observer/filing/0001213900-23-083513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/0001213900-23-083513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/ea187691-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T22:47:29.713283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b1c8ea127c2daf394258e4681a1d9211d219292","claim":"60 DEGREES PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).","evidence_excerpt":"arket pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390023083513/0001213900-23-083513-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}